ClinicalTrials.gg

Program

MK-2060

A development code.

Its studies are mostly in Kidney Failure, Chronic · Venous Thrombosis, led by Merck.

Furthest: phase 2, since Aug 26, 20217 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Merck70 open or runningphase 2since Aug 26, 2021Mar 12, 2019none ahead

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Mar 12, 2019First study: phase 1 study in Kidney Failure, ChronicFirst studyNCT03873038 · 38 enrolled · United States
  2. Aug 26, 2021Phase 2 study in Kidney Failure, ChronicNCT05027074 · 506 enrolled · United States, Argentina, Australia and more
  3. Apr 12, 2022Phase 1 study in Kidney Failure, ChronicNCT05335005 · 12 enrolled · United States, Israel, Romania
  4. Dec 9, 2022Phase 1 study in Kidney Failure, ChronicNCT05656040 · 14 enrolled · United States
  5. Mar 3, 2023Phase 1 study in Kidney Failure, ChronicNCT05769595 · 17 enrolled · Japan
  6. Aug 30, 2024Phase 1 study in Venous ThrombosisNCT06582602 · 23 enrolled · United States
  7. Feb 19, 2025Phase 1 study in HealthyNCT06843993 · 36 enrolled · China

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 7 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06843993Healthy · China1CompletedOct 27, 202336
NCT06582602Venous Thrombosis · United States1CompletedApr 18, 202523
NCT05769595Kidney Failure, Chronic · Japan1CompletedFeb 15, 202417
NCT05656040Kidney Failure, Chronic · United States1CompletedAug 12, 202414
NCT05335005Kidney Failure, Chronic · United States, Israel, Romania1CompletedFeb 14, 202312
NCT05027074Kidney Failure, Chronic · United States, Argentina, Australia and more2CompletedOct 30, 2024506
NCT03873038Kidney Failure, Chronic · United States1CompletedDec 20, 202138

How it is read

Names in the registry

  • “MK-2060”, 7 entries

Codes read as this program: MK2060.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.